2022

  • Celebrated physician and author to reflect on heroism in healthcare at Opening Session

    Celebrated physician and author to reflect on heroism in healthcare at Opening Session

    Best-selling author Abraham Verghese, MD, will present the Keynote Lecture during the Opening Session of ACR Convergence 2022. As attendees gather in person for the first time since 2019, he said it is necessary to acknowledge the unprecedented period of struggle and valor experienced across…

  • Potential of precision medicine in rheumatology grows

    Potential of precision medicine in rheumatology grows

    Omic technologies are revealing disease subtypes and molecular targets that allow for more targeted and effective treatment for rheumatic disease. Andrea Fava, MD, will discuss the molecular dissection of lupus nephritis through urine proteomics in a session on precision medicine.

  • Claim CME/MOC for ACR Convergence 2022

    Claim CME/MOC for ACR Convergence 2022

    The deadline to claim CME credit and MOC points for in-person and virtual participation in the 2022 meeting is November 11, 2023.

  • Chris Dunn: Radiographic Osteoarthritis Progression Can Be Predicted via Pyrosequencing Analysis of Baseline Peripheral Blood

    Chris Dunn: Radiographic Osteoarthritis Progression Can Be Predicted via Pyrosequencing Analysis of Baseline Peripheral Blood

    Graduate student Chris Dunn will discuss the poster “Radiographic Osteoarthritis Progression Can Be Predicted via Pyrosequencing Analysis of Baseline Peripheral Blood” in a Saturday afternoon Ignite Talk.

  • Michelle Barraclough, PhD: Evolution of Subjective Cognitive Impairment Over Time in SLE Patients: Bayesian Longitudinal Item Response Theory Modelling

    Michelle Barraclough, PhD: Evolution of Subjective Cognitive Impairment Over Time in SLE Patients: Bayesian Longitudinal Item Response Theory Modelling

    Michelle Barraclough, PhD, will discuss the poster “Evolution of Subjective Cognitive Impairment Over Time in SLE Patients: Bayesian Longitudinal Item Response Theory Modelling” in a Sunday morning Ignite Talk.

  • Jose A. Gómez-Puerta, MD, PhD, MPH: Vaccination Against SARS-CoV-2 in Patients with Systemic Autoimmune Diseases: A Safety Report from EULAR COVAX Registry

    Jose A. Gómez-Puerta, MD, PhD, MPH: Vaccination Against SARS-CoV-2 in Patients with Systemic Autoimmune Diseases: A Safety Report from EULAR COVAX Registry

    Jose A. Gómez-Puerta, MD, PhD, MPH, will discuss the poster “Vaccination Against SARS-CoV-2 in Patients with Systemic Autoimmune Diseases: A Safety Report from EULAR COVAX Registry” in a Sunday afternoon Ignite Talk.

  • Ardy Fenando, MD: Autonomic Dysfunction in Sjögren’s Disease

    Ardy Fenando, MD: Autonomic Dysfunction in Sjögren’s Disease

    Ardy Fenando, MD, will discuss the poster “Autonomic Dysfunction in Sjögren’s Disease” in a Monday afternoon Ignite Talk.

  • Plenaries present the best of the best 2022 abstracts in rheumatology

    Plenaries present the best of the best 2022 abstracts in rheumatology

    Three plenary sessions over three days will highlight the latest discoveries, cutting-edge technology, emerging trends, and new clinical approaches for rheumatologic disease. The goal of all of the included studies is to improve upon the work being done in the field on behalf of patients,…

  • Year in Review to focus on top basic and clinical science

    Year in Review to focus on top basic and clinical science

    Carol Langford, MD, MHS, will discuss cutting-edge advancements in clinical science from the past year, including new approaches to rheumatoid arthritis, lupus, spondyloarthritis, and myositis treatment. John Varga, MD, will discuss emerging developments in basic science, including single-cell RNA sequencing and other high-throughput technologies.

  • Panelists to provide rheumatology update on COVID-19

    Panelists to provide rheumatology update on COVID-19

    The convergence between rheumatology and infectious disease presented by COVID-19 continues to surprise patients, clinicians, researchers, industry, regulators, and other stakeholders. Stephen Saw, PharmD, BCIDP, is among the experts who will discuss the ongoing implications of this disease on rheumatology.